.While the biotech assets scene in Europe has slowed rather following a COVID-19 backing boom in 202...
.After bring up $213 million in 2023-- some of the year's most extensive personal biotech rounds-- V...
.Invite to this week's Chutes & Ladders, our roundup of considerable leadership hirings, shooting...
.Financial backing backing right into biopharma cheered $9.2 billion around 215 deals in the 2nd fou...
.Bicara Therapies and Zenas Biopharma have actually delivered fresh impetus to the IPO market along ...
.Genentech is going to shut its cancer immunology research department, as well as unit mind as well ...
.Kezar Life Sciences is losing its unpromising period 1 strong lump medication as the biotech goes a...
.Regardless of izokibep sustaining its own newfound winning touch in the center, Acelyrin is actuall...
.Rivus Pharmaceuticals has actually plumped up the leads of its own fat-busting, muscle-sparing drug...
.Ovid Therapy currently showed final month that it was actually trimming its headcount as the busine...